simvastatin/ezetimibe + atorvastatin 20mg
ApprovedUNKNOWN 1 views this week 0 watching💤 Quiet
Interest: 39/100
39
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Type 2 Diabetes Mellitus Without Insulin Treatment
Conditions
Type 2 Diabetes Mellitus Without Insulin Treatment
Trial Timeline
Sep 1, 2010 → Aug 1, 2011
NCT ID
NCT01185236About simvastatin/ezetimibe + atorvastatin 20mg
simvastatin/ezetimibe + atorvastatin 20mg is a approved stage product being developed by Merck for Type 2 Diabetes Mellitus Without Insulin Treatment. The current trial status is unknown. This product is registered under clinical trial identifier NCT01185236. Target conditions include Type 2 Diabetes Mellitus Without Insulin Treatment.
What happened to similar drugs?
20 of 20 similar drugs in Type 2 Diabetes Mellitus Without Insulin Treatment were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
20
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01185236 | Approved | UNKNOWN |
Competing Products
20 competing products in Type 2 Diabetes Mellitus Without Insulin Treatment